Three-dose Chinese vaccine for COVID-19 gets approval for human trials in Pakistan
China’s Sinopharm and CanSino, UK’s AstraZeneca and Russia's Sputnik V jabs have already been granted emergency use authorisation China’s Sinopharm and CanSino, UK’s AstraZeneca and Russia's Sputnik V jabs have already been granted emergency use authorisation
Post a Comment